---
schema_version: "secwatch.filing_event.v1"
accession: "0000719135-24-000023"
form_type: "8-K"
ticker: "APYX"
cik: "0000719135"
company_name: "Apyx Medical Corp"
filed_at: "2024-05-09T23:59:59+00:00"
generated_at: "2026-06-02T07:33:40.534045+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Apyx Medical appoints Stavros Vizirgianakis as Chairman; founder Andrew Makrides retires after 40+ years

## Summary
- Andrew Makrides retired as Chairman effective May 7, 2024, after serving since 1982.
- Stavros Vizirgianakis appointed Chairman and director to fill vacancy; term expires at 2024 annual meeting.
- Vizirgianakis is a former CEO of Misonix and current director of Xtant Medical and Medinotec.
- Agreement includes standstill until 2025 annual meeting, limiting ownership to 9.9% and requiring vote with Board.
- Board and Vizirgianakis will cooperate to identify an additional director within six months if he holds 5%+ shares.

## SEC filing metadata
- accession: 0000719135-24-000023
- form_type: 8-K
- ticker: APYX
- cik: 0000719135
- company_name: Apyx Medical Corp
- filed_at: 2024-05-09T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 1.01, 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/719135/000071913524000023/0000719135-24-000023-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/719135/000071913524000023/apyx-20240507.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000719135-24-000023
- JSON: https://secwatch.observer/filing/0000719135-24-000023.json
- Plain text: https://secwatch.observer/filing/0000719135-24-000023.txt

## Key facts
- Executive change
  Andrew Makrides retired as Chairman of the Board at Apyx Medical Corp.
  - Action: retired
  - Role: Chairman of the Board
  source text: On May 7, 2024, Andrew Makrides announced his retirement as a director and Chairman of the Board, effective on the same date.
  evidence_url: https://www.sec.gov/Archives/edgar/data/719135/000071913524000023/0000719135-24-000023-index.htm
- Executive change
  Stavros Vizirgianakis was appointed as Director and Chairman of the Board at Apyx Medical Corp.
  - Action: appointed
  - Role: Director and Chairman of the Board
  source text: On May 7, 2024, the Board appointed Mr. Vizirgianakis to serve as a director and Chairman of the Board, to fill the vacancy created by the retirement of Andrew Makrides.
  evidence_url: https://www.sec.gov/Archives/edgar/data/719135/000071913524000023/0000719135-24-000023-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.